Literature DB >> 224064

Prostaglandin E2 and cyclic AMP levels in human breast tumors.

N Feller, T Malachi, I Halbrecht.   

Abstract

Prostaglandin E2 (PGE2) and cyclic adenosine-3', 5'-monophosphate (cAMP) concentrations were measured in human benign and malignant breast tumors by radioimmunoassay. Two groups were found among the malignant tissues, one with high PGE2 (M = 65.89 pg/mg) and high cAMP (M = 0.704 pmole/mg) concentrations and one with low concentrations (M = 9.24 pg/mg and M = 0.299 pmole/mg, respectively). The low PGE2 levels in the malignant tumors did not differ significantly from the levels found in benign tumors (M = 8.06 pg/mg). cAMP levels were positively and highly correlated (r = +0.81) with PGE2 levels. No bone osteolysis could be discovered in any of the patients a few weeks after mastectomy operation, but PGE2 analysis of breast tumors may have prognostic value for the future.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 224064     DOI: 10.1007/bf00964583

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  16 in total

1.  Cyclic AMP and cyclic GMP content and binding in malignancy.

Authors:  M L Goldberg; G C Burke; H P Morris
Journal:  Biochem Biophys Res Commun       Date:  1975-01-20       Impact factor: 3.575

2.  Altered levels of cyclic nucleotides, cyclic AMP phosphodiesterase and adenylyl cyclase activities in normal, dysplastic and neoplastic human mammary tissue.

Authors:  W Küng; E Bechtel; E Geyer; A Salokangas; J Preisz; P Huber; J Torhorst; R A Jungmann; K Talmadge; U Eppenberger
Journal:  FEBS Lett       Date:  1977-10-01       Impact factor: 4.124

3.  Human breast tumour-induced osteolysis and prostaglandins.

Authors:  M Dowsett; G C Easty; T J Powles; D M Easty; A M Neville
Journal:  Prostaglandins       Date:  1976-03

4.  Instability of 13, 14-dihydro-15-keto-prostaglandin E2.

Authors:  M D Mitchell; H Sors; A P Flint
Journal:  Lancet       Date:  1977-09-10       Impact factor: 79.321

5.  Prostaglandins and metastasis.

Authors:  W E Kibbey; D G Bronn; J P Minton
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

6.  Plasma prostaglandin E in patients with cancer with and without hypercalcemia.

Authors:  R P Robertson; D J Baylink; S A Metz; K B Cummings
Journal:  J Clin Endocrinol Metab       Date:  1976-12       Impact factor: 5.958

7.  Prostaglandin production by normal and transformed 3T3 fibroblasts in cell culture.

Authors:  S Hammarström
Journal:  Eur J Biochem       Date:  1977-03-15

8.  Rat osteogenic sarcoma cells:effects of some prostaglandins, their metabolites and analogues on cyclic AMP production.

Authors:  D Atkins; T J Martin
Journal:  Prostaglandins       Date:  1977-05

9.  Effects of prostaglandins and other drugs on the cyclic AMP content of cultured bone cells.

Authors:  J H Yu; H Wells; W J Ryan; W S Lloyd
Journal:  Prostaglandins       Date:  1976-10

10.  Elevated adenosine 3',5'-cyclic monophosphate levels in human and animal tumors in vivo.

Authors:  J P Minton; R H Matthews; T W Wisenbaugh
Journal:  J Natl Cancer Inst       Date:  1976-07       Impact factor: 13.506

View more
  2 in total

1.  Role of natural prostaglandins in the control of murine mammary tumor virus expression.

Authors:  J Svec; P Svec; L Halcak; V Thurzo
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

2.  Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients.

Authors:  T Malachi; C Chaimoff; N Feller; I Halbrecht
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.